Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India’s Punjab State Bans Drug Rep Visits To Docs During Patient Hours

This article was originally published in PharmAsia News

Executive Summary

The government of the Indian state of Punjab has banned physician meetings with pharmaceutical representatives during working hours. Punjab's Medical Education and Research minister said the ban is aimed at such encounters during the visiting hours of general patients. The intent is to avoid such meetings, which often cause patients to have to wait longer to see their physician, sometimes for hours. The rule is to apply to all doctors, in public or private practice, who work in medical institutes and hospitals. The rule allows the meetings after 2 p.m. if the doctor has seen all waiting patients. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069182

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel